$0.97
9.62% yesterday
Nasdaq, Nov 25, 10:06 pm CET
ISIN
US64131A1051
Symbol
STIM

Neuronetics, Inc. Stock price

$0.97
-0.02 2.01% 1M
-1.21 55.50% 6M
-1.93 66.55% YTD
-0.45 31.68% 1Y
-3.34 77.49% 3Y
-3.25 77.01% 5Y
-26.81 96.51% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.09 9.62%
ISIN
US64131A1051
Symbol
STIM

Key metrics

Market capitalization $29.44m
Enterprise Value $56.70m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.78
P/S ratio (TTM) P/S ratio 0.40
P/B ratio (TTM) P/B ratio 3.14
Revenue growth (TTM) Revenue growth 5.03%
Revenue (TTM) Revenue $72.71m
EBIT (operating result TTM) EBIT $-27.52m
Free Cash Flow (TTM) Free Cash Flow $-22.52m
Cash position $21.44m
EPS (TTM) EPS $-1.22
P/E forward negative
P/S forward 0.41
EV/Sales forward 0.79
Short interest 2.59%
Show more

Is Neuronetics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Neuronetics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Neuronetics, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Neuronetics, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Neuronetics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
73 73
5% 5%
100%
- Direct Costs 20 20
8% 8%
27%
53 53
11% 11%
73%
- Selling and Administrative Expenses 69 69
1% 1%
95%
- Research and Development Expense 9.21 9.21
12% 12%
13%
-25 -25
19% 19%
-35%
- Depreciation and Amortization 2.13 2.13
1% 1%
3%
EBIT (Operating Income) EBIT -28 -28
17% 17%
-38%
Net Profit -36 -36
10% 10%
-50%

In millions USD.

Don't miss a Thing! We will send you all news about Neuronetics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neuronetics, Inc. Stock News

Neutral
GlobeNewsWire
6 days ago
MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team will present at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024. The...
Neutral
Seeking Alpha
13 days ago
Neuronetics, Inc. (NASDAQ:STIM ) Q3 2024 Earnings Call November 12, 2024 8:30 AM ET Company Participants Mark Klausner - Investor Relations Keith Sullivan - President and Chief Executive Officer Steve Furlong - Chief Financial Officer Conference Call Participants William Plovanic - Canaccord Genuity James Beers - William Blair Danny Stauder - JMP Operator Good day and thank you for standing by....
Neutral
GlobeNewsWire
14 days ago
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the "Stockholders Approve Acquisition of Greenbrook TMS" section, it should say that the Company expects to achieve cash flow breakeven by the third quarter of 2025, not the second. The corrected release follows:
More Neuronetics, Inc. News

Company Profile

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

Head office United States
CEO Keith Sullivan
Employees 203
Founded 1998
Website www.neurostar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today